Helius Medical Technologies logo
Helius Medical Technologies HSDT
$ 2.01 -6.94%

Quarterly report 2025-Q3
added 11-18-2025

report update icon

Helius Medical Technologies Financial Statements 2011-2026 | HSDT

Annual Financial Statements Helius Medical Technologies

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.54 M 72.9 K 11.4 M 16.1 M 25.8 M 170 M 196 M 74.5 M 125 M - - - -

Shares

608 K 270 K 2.46 M 1.2 M 753 K 651 K 532 K 380 K 326 K - - - -

Historical Prices

5.83 0.27 4.64 13.6 31.9 248 422 285 133 457 - - -

Net Income

-8.85 M -14.1 M -18.1 M -14.1 M -9.78 M -28.6 M -28 M -6.88 M -8.89 M -1.07 M - - -

Revenue

644 K 787 K 522 K 661 K 1.5 M 478 K - - - - - - -

Cost of Revenue

583 K 463 K 298 K 388 K 846 K - - - - - - - -

Gross Profit

61 K 324 K 224 K 273 K 650 K - - - - - - - -

Operating Income

-12.4 M -15.5 M -18.1 M -14.4 M -24 M -26.7 M -22.9 M -9.32 M -9.81 M -1.07 M -8.52 M - -

Interest Expense

- - - - - - - 46.9 K 176 K - - - -

EBITDA

-12.4 M -15.4 M -18 M -14 M -23.9 M -26.6 M -22.8 M -9.17 M -8.84 M -1.07 M -8.52 M - -

Operating Expenses

12.5 M 15.8 M 18.4 M 14.7 M 24.6 M 27.2 M 22.9 M 9.32 M 8.86 M - - - -

General and Administrative Expenses

9.27 M 10.6 M 12.2 M - - 17.2 M 8.47 M 5.67 M 4.26 M 896 K 4.27 M - -

All numbers in USD currency

Quarterly Income Statement Helius Medical Technologies

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

10.7 M 123 K 7.56 M 4.94 K 4.95 K 3.32 K 817 K 715 K 668 K 564 K 564 K 564 K 356 K 3.93 M 3.79 M 3.78 M 2.33 M 2.32 M 2.04 M 1.48 M 1.29 M 1.16 M 885 K 878 K 25.9 M 25.9 M 25.8 M 25.8 M 23.4 M 22.9 M 20.3 M 20.2 M 19.2 M 18.3 M 17.6 M 16.9 M 84.4 M 81 M 71.8 M 65 M 64.4 M 64.1 M 63.1 M 63.1 M 63.1 M 51 M 38.8 M - - - - - - - - - - - -

Net Income

-353 M -9.83 M -3.84 M - -3.69 M -1.61 M -2.52 M - -3.66 M -1.65 M -2.49 M - -1.03 M -3.81 M -4.35 M - -4.69 M -5.98 M -3.36 M - -3.48 M -3.36 M -4.76 M - -5.59 M -186 K 1.32 M - -4.52 M -17.8 M -1.16 M - -12.9 M -5.68 M -5.68 M - -2.99 M -3.08 M -3.83 M -2.43 M 1.79 M -769 K - -2.48 M -2.48 M -3.76 M -1.56 M - - - -8.52 M - - - - - - - -

Revenue

697 K 43 K 49 K - 51 K 182 K 135 K - 143 K 256 K 111 K - 196 K 119 K 190 K - 109 K 71 K 84 K - 131 K 133 K 207 K - 150 K 518 K 677 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

103 K 96 K 121 K - 187 K 118 K 123 K - 187 K 184 K 122 K - 101 K 88 K 124 K - 86 K 67 K 15 K - 22 K 64 K 101 K - 89 K 212 K 236 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

594 K -53 K -72 K - -136 K 64 K 12 K - -44 K 72 K -11 K - 95 K 31 K 66 K - 23 K 4 K 69 K - 109 K 69 K 106 K - 61 K 306 K 441 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-35.4 M -3.32 M -4.01 M - -4.07 M -3.27 M -3.42 M - -3.15 M -3.22 M -3.81 M - -4.85 M -3.43 M -4.56 M - -4.37 M -6.17 M -3.5 M - -3.66 M -3.72 M -4 M - -5.74 M -5.81 M -6.82 M - -4.89 M -11.8 M -4.72 M - -5.97 M -5.98 M -5.03 M - -3.39 M -2.1 M -2.92 M -2.84 M -726 K -3.71 M - -3.09 M -3.09 M -2.76 M -1.38 M - - - - - - - - - - - -

Interest Expense

-154 K -420 K - - 233 K 71 K - - - - - - - - - - - - - - - 56 K 6 K - 11 K 13 K 11 K - - - - - - - - - -20 K - -20.4 K 26.1 K - 53 - - - - 176 K - - - - - - - - - - - -

EBITDA

- - -4 M - -4.06 M -3.26 M -3.41 M - -3.12 M -3.18 M -3.8 M - -4.81 M -3.38 M -4.54 M - -4.29 M -6.11 M -3.47 M - -3.63 M -3.69 M -3.96 M - -5.69 M -5.79 M -6.8 M - -4.85 M -11.8 M -4.71 M - -5.96 M -5.98 M -5.03 M - -3.39 M -2.1 M -2.92 M -2.84 M -726 K -3.71 M - -3.09 M -3.09 M -2.76 M -1.38 M - - - - - - - - - - - -

Operating Expenses

36 M 3.27 M 3.94 M - 3.93 M 3.33 M 3.43 M - 3.11 M 3.29 M 3.8 M - 4.95 M 3.46 M 4.63 M - 4.4 M 6.17 M 3.57 M - 3.77 M 3.79 M 4.11 M - 5.8 M 6.12 M 7.26 M - 4.89 M 11.8 M 4.72 M - 5.97 M 5.98 M 5.03 M - 3.39 M 2.1 M 2.92 M - 726 K 3.71 M - - - - - - - - - - - - - - - - -

General and Administrative Expenses

4.65 M 2.45 M 2.99 M - 2.86 M 2.46 M 2.63 M - 2.2 M 2.57 M 2.87 M - 3.39 M 2.46 M 2.82 M - 2.86 M 4.74 M 2.2 M - 2.37 M 2.39 M 2.86 M - 4.29 M 3.84 M 4.58 M - 2.58 M 8.89 M 2.16 M - 2.17 M 1.68 M 2.01 M - 1.98 M 1.45 M 1.93 M 30.4 K 724 K 2.19 M - 45.5 K 45.5 K 83.7 K 21.4 K - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Helius Medical Technologies HSDT
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Helius Medical Technologies plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.13 -0.76 % $ 327 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.38 -1.78 % $ 722 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Inogen Inogen
INGN
$ 6.5 1.25 % $ 173 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.35 1.89 % $ 21.8 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 98.74 -2.99 % $ 1.26 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 16.35 0.74 % $ 384 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
LENSAR LENSAR
LNSR
$ 5.52 -1.08 % $ 63.6 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 36.64 -1.19 % $ 1.14 B usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 87.67 -0.24 % $ 113 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Electromed Electromed
ELMD
$ 24.45 -0.85 % $ 207 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Orthofix Medical Orthofix Medical
OFIX
$ 11.79 -1.17 % $ 467 M curacaoCuracao
Outset Medical Outset Medical
OM
$ 3.52 -0.28 % $ 53.5 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.6 -10.61 % $ 32.7 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 2.27 -2.16 % $ 3.54 M usaUSA
PAVmed PAVmed
PAVM
$ 8.94 -3.87 % $ 64.7 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 63.65 0.55 % $ 3.47 B britainBritain
InspireMD InspireMD
NSPR
$ 1.73 -2.26 % $ 111 M israelIsrael
Insulet Corporation Insulet Corporation
PODD
$ 218.11 0.98 % $ 15.3 B usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.41 0.18 % $ 1.54 B usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.9 -1.52 % $ 166 M usaUSA
Penumbra Penumbra
PEN
$ 336.42 0.04 % $ 13.1 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 3.94 -3.9 % $ 582 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
Myomo Myomo
MYO
$ 0.68 -2.2 % $ 28.5 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 50.45 -1.87 % $ 1.48 B usaUSA